Factors Affecting Valrubicin Response in Patients with Bacillus Calmette-Guérin–Refractory Bladder Carcinoma in Situ

2011 ◽  
Vol 123 (3) ◽  
pp. 28-34 ◽  
Author(s):  
Gary D. Steinberg ◽  
Norm D. Smith ◽  
Kevin Ryder ◽  
Nicole M. Strangman ◽  
Simon J. Slater
Keyword(s):  
Bladder Carcinoma ◽  
Carcinoma In Situ ◽  
Bacillus Calmette Guerin ◽  
Factors Affecting

Factors Affecting Response to Bacillus Calmette-Guérin Plus Interferon for Urothelial Carcinoma in Situ

2011 ◽  
Vol 186 (3) ◽  
pp. 817-823 ◽  
Author(s):  
Henry M. Rosevear ◽  
Andrew J. Lightfoot ◽  
Kevin K. Birusingh ◽  
José L. Maymí ◽  
Kenneth G. Nepple ◽  
...  
Keyword(s):  
Urothelial Carcinoma ◽  
Carcinoma In Situ ◽  
Bacillus Calmette Guerin ◽  
Factors Affecting

Contemporary outcomes of bladder carcinoma in situ treated with an adequate BCG immunotherapy

2021 ◽  
Author(s):  
José Daniel Subiela ◽  
Óscar Rodríguez Faba ◽  
Júlia Aumatell ◽  
Julio Calderón ◽  
Asier Mercadé ◽  
...  
Keyword(s):  
Bladder Carcinoma ◽  
Carcinoma In Situ ◽  
Bcg Immunotherapy

Cyclin D3 gene amplification in bladder carcinoma in situ

2010 ◽  
Vol 457 (5) ◽  
pp. 555-561 ◽  
Author(s):  
Antonio Lopez-Beltran ◽  
Jose L. Ordóñez ◽  
Ana P. Otero ◽  
Ana Blanca ◽  
Vicky Sevillano ◽  
...  
Keyword(s):  
Gene Amplification ◽  
Bladder Carcinoma ◽  
Carcinoma In Situ ◽  
Cyclin D3

1034 CLINICAL OUTCOMES OF PRIMARY BLADDER CARCINOMA IN SITU IN A CONTEMPORARY SERIES

2010 ◽  
Vol 9 (2) ◽  
pp. 324
Author(s):  
D. Chade ◽  
S.F. Shariat ◽  
G. Godoy ◽  
C. Savage ◽  
A. Cronin ◽  
...  
Keyword(s):  
Clinical Outcomes ◽  
Bladder Carcinoma ◽  
Carcinoma In Situ ◽  
Primary Bladder
Sign in / Sign up

Export Citation Format

Share Document